MARKET

PPH

PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

64.81
-0.05
-0.08%
After Hours: 65.20 +0.39 +0.60% 17:00 11/25 EST
OPEN
64.71
PREV CLOSE
64.86
HIGH
64.81
LOW
64.39
VOLUME
11.97K
TURNOVER
--
52 WEEK HIGH
68.02
52 WEEK LOW
46.90
TOTAL ASSET
217.48M
YTD YIELD
-1.48%
1D
5D
1M
3M
1Y
5Y
News
Performance
Write A Prescription For This Pharma ETF
After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccine progress.
Benzinga · 1d ago
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.2493
VanEck Vectors Pharmaceutical ETF (PPH) - $0.2493.30-Day SEC Yield of 1.67% as of Sept. 30.Payable Oct 07; for shareholders of record Oct 02; ex-div Oct 01.
Seekingalpha · 10/01 16:59
Eli Lilly Q1 Earnings Call Key Takeaways
Seeking Alpha - Article · 04/27 11:22
Sanders' big Nevada primary win shakes health-related stocks
Seeking Alpha - Article · 02/24 15:10
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10 14:35
Quality Play With Pharma ETFs
Seeking Alpha - Article · 12/11/2019 20:05
Pharma Still Stressed
Seeking Alpha - Article · 11/25/2019 17:43
FDA OK'd record number of generic drugs in F19
Seeking Alpha - Article · 10/16/2019 16:42
More
No Data
Learn about the latest financial forecast of PPH. Analyze the recent business situations of VanEck Vectors Pharmaceutical ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-2.9895%
--
3-Month
-1.3098%
--
6-Month
4.8724%
--
1-Year
-1.4781%
--
3-Year
5.9871%
--
5-Year
0.5642%
--
Since Inception
8.8357%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin